These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 14565169)
1. Metabolic Diseases Drug Discovery World Summit--SRI conference. 28-29 July 2003 San Diego, CA, USA. Knittel T IDrugs; 2003 Sep; 6(9):845-9. PubMed ID: 14565169 [No Abstract] [Full Text] [Related]
2. Metabolic Diseases Drug Discovery World Summit--SRI conference. Diabetes and obesity. 28-29 July 2003 San Diego, CA, USA. Xu J IDrugs; 2003 Sep; 6(9):850-1. PubMed ID: 14565170 [No Abstract] [Full Text] [Related]
3. Metabolic Diseases Drug Discovery World Summit. Liu G Expert Opin Emerg Drugs; 2003 Nov; 8(2):577-82. PubMed ID: 14662006 [TBL] [Abstract][Full Text] [Related]
4. Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. PPAR and PTB1B modulators 26-27 July 2004, San Diego, CA, USA. Xu J IDrugs; 2004 Sep; 7(9):836-8. PubMed ID: 15470599 [No Abstract] [Full Text] [Related]
5. Protein phosphorylation drug discovery summit--SRI conference. Targeting kinases and phosphatases for novel therapeutics. 3-5 March 2003, San Diego, CA, USA. Stokoe D IDrugs; 2003 May; 6(5):432-6. PubMed ID: 12841205 [No Abstract] [Full Text] [Related]
6. Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA. Nock S IDrugs; 2004 Sep; 7(9):825-8. PubMed ID: 15470596 [TBL] [Abstract][Full Text] [Related]
7. Genomics, Signaling and Tumor Targeting--Sidney Kimmel Cancer Center Inaugural Conference. 16-18 February 2004, San Diego, CA, USA. Leoni L; Niemeyer C; Bendall H IDrugs; 2004 Apr; 7(4):312-4. PubMed ID: 15057632 [No Abstract] [Full Text] [Related]
8. Noordwijkerhout-Camerino--15th Symposium. Trends in drug research. Triggle DJ IDrugs; 2005 Jul; 8(7):563-6. PubMed ID: 15973564 [No Abstract] [Full Text] [Related]
9. Discontinued drugs in 2008: endocrine and metabolic. Colca JR Expert Opin Investig Drugs; 2009 Sep; 18(9):1243-55. PubMed ID: 19678796 [TBL] [Abstract][Full Text] [Related]
10. Metabolic Diseases World Summit 2005. Partnering and deal-making. 29 June-1 July 2005, San Francisco, CA, USA. Clark AG IDrugs; 2005 Sep; 8(9):708-9. PubMed ID: 16118687 [No Abstract] [Full Text] [Related]
11. GSK3 inhibitors: development and therapeutic potential. Cohen P; Goedert M Nat Rev Drug Discov; 2004 Jun; 3(6):479-87. PubMed ID: 15173837 [No Abstract] [Full Text] [Related]
12. Lapatinib ditosylate GlaxoSmithKline. Kim TE; Murren JR IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069 [TBL] [Abstract][Full Text] [Related]
13. HIV pathogenesis and treatment--second International AIDS Society conference. 13-16 July 2003, Paris, France. Susman E IDrugs; 2003 Sep; 6(9):865-7. PubMed ID: 14565176 [No Abstract] [Full Text] [Related]
15. Cambridge Healthtech Institute Drug Discovery Chemistry. San Diego, CA, USA, 12-14 April, 2011. Sherman W; Salam N; Warshaviak D Future Med Chem; 2011 Sep; 3(12):1465-7. PubMed ID: 21882939 [No Abstract] [Full Text] [Related]
16. Metabolic Diseases World Summit 2005. 29 June-1 July 2005, San Francisco, CA, USA. James S IDrugs; 2005 Sep; 8(9):704-7. PubMed ID: 16118686 [No Abstract] [Full Text] [Related]
17. M-40403 Metaphore Pharmaceuticals. Di Napoli M; Papa F IDrugs; 2005 Jan; 8(1):67-76. PubMed ID: 15650944 [TBL] [Abstract][Full Text] [Related]